What happened? HMOs like United Health Medicare-Advantage are using the patient list of professional eye doctors to introduce discounted & experimental procedures for select groups that have health care managed for shareholder profit. While these programs are technically legal under CMS guidelines, they raise ethical concerns when: (1) Patients aren’t fully informed. (2) Procedures are marketed as “discounted” but lack proven outcomes. (3) Decisions are driven by cost containment and shareholder profit, not patient well-being.
What would you like to see happen? I’d like to see patients get organized for what is likely to be a long and experimental journey in health care for the most vulnerable. The movement needed must include (1) Patient organizing around the long-term implications of experimental care. (2) Collaborative action rooted in firsthand accounts—not just abstract policy debates. (3) Productive response systems that validate and act on what patients say happened.
How do you think others can help? Join organizing efforts that offer productive responses and is dedicated to organizing patient firsthand accounts of what happened for collaborative action. Encourage watchdog efforts to: (1) Monitor how AI is used in patient selection and treatment. (2) Compare outcomes of experimental procedures vs. standard care. (3) Push for transparency in HMO decision-making.
For more information or to offer a productive response to a mate3 answer set presented here, please contact Cayman by email at mate3@mate3.com and by voicemail at 3137426018. The benefit of mate3.com networking is to organize around what the affected person says happened. We find, connect and provide productive responses to what is said to have happened.
Comments
Post a Comment